While its shares have been lagging the market significantly, that could change in the next decade as financial results ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

Pfizer-BioNTech's COVID-19 vaccine, which was once hailed as a lifesaver, has been found to have subtle but serious side ...

It might be prudent to make a point of collecting a little more cash in the near future, and worry a little less about growth ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

Our warm weather season is short, and it’s important to enjoy the outdoors. The point isn’t to be sun-scared — just stay ...

A new study suggests a potential link between the Pfizer COVID-19 vaccine and serious eye conditions like retinal vascular ...

You can buy shares of Healthpeak Properties and Pfizer with well less than $100 at the moment. At the moment, anyone with ...

Sally Susman says there's no average day in her field and explains why she doesn't see comms as a 'soft skill.' ...

Pfizer Inc. (NYSE:PFE) hasn’t performed well in recent years, with its stock declining more than 26% over the past decade.

Pfizer, Inc. (NYSE:PFE) is one of the high-margin pharma stocks to buy now. Bristol-Myers Squibb Company (NYSE:BMY) and ...

Pfizer and Bristol Myers Squibb have launched a direct-to-patient program offering their blood thinner Eliquis at a 40% discount for cash-paying patients.  The list price for Eliquis (apixaban) is ...